Hedge Funds Gain Big After Amlin $AMLN Reports Higher Than Expected

Amlin Pharmaceuticals (AMLN) rose 11.13% on Thursday morning after it reported a GAAP loss of 9 cents per share, which was narrower than the 15 cents per share loss estimated by analysts reports NASDAQ. AMLN’s revenues also exceeded expectations. Shares rose from $10.24 at close yesterday to trade at $11.70 a share as of 9:50 am this morning.

ICAHN CAPITAL Carl Icahn
The following hedge funds made the most:

1. Visium Asset Management – Jacob Gottlieb: Gained $24.9 million

2. Icahn Capital Lp – Carl Icahn: Gained $20.9 million

3. Sac Capital Advisors – Steven Cohen: Gained $10.3 million

4. Partner Fund Management – Christopher Medlock James: Gained $3.3 million

5. Millennium Management – Israel Englander: Gained $1.0 million

6. Renaissance Technologies – Jim Simons: Gained $1.0 million

7. Caxton Associates Lp – Bruce Kovner: Gained $525,000

8. Alyeska Investment Group – Anand Parekh: Gained $434,000

9. Kingdon Capital Management - Mark Kingdon: Gained $379,000

10. D E Shaw - D. E. Shaw: Gained $131,000

DISCLAIMER: These calculations assume that these hedge funds did not increase or reduce their stock positions in AMLN since the end of June. We did not take into account their option positions.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!